Compare CRTO & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRTO | IART |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2013 | 1995 |
| Metric | CRTO | IART |
|---|---|---|
| Price | $20.40 | $13.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $38.67 | $15.00 |
| AVG Volume (30 Days) | 471.4K | ★ 810.8K |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.79 | N/A |
| EPS | ★ 3.00 | N/A |
| Revenue | ★ $1,956,800,000.00 | $1,642,966,000.00 |
| Revenue This Year | N/A | $3.26 |
| Revenue Next Year | $1.42 | $2.71 |
| P/E Ratio | $7.01 | ★ N/A |
| Revenue Growth | 0.53 | ★ 4.99 |
| 52 Week Low | $19.00 | $10.87 |
| 52 Week High | $47.27 | $27.13 |
| Indicator | CRTO | IART |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 51.44 |
| Support Level | $19.00 | $12.81 |
| Resistance Level | $21.48 | $13.82 |
| Average True Range (ATR) | 0.78 | 0.57 |
| MACD | 0.08 | 0.19 |
| Stochastic Oscillator | 56.45 | 72.51 |
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.